PeptiCRAd – A Novel Cancer Immunotherapy Approach Targeting Multiple Tumour Antigens

Time: 4:45 pm
day: Day Two


  • PeptiCRAd is a cutting-edge cancer immunotherapy approach that targets multiple tumor antigens simultaneously
  • By targeting multiple tumor antigens, PeptiCRAd increases the likelihood of immune recognition and response against a wide range of cancer types
  • PeptiCRAd has the potential to be a highly effective and versatile cancer immunotherapy, with applications in various cancer types